Black and Hispanic women typically have lower levels of circulating Vitamin D than white women, which may contribute to an increased risk of breast cancer, new research suggests.
A study found that participants with sufficient levels of vitamin D had a 21% lower breast cancer rate than those with a vitamin D deficiency. The benefits of vitamin D were particularly significant for Hispanic women, who had a 48% lower rate of breast cancer if they had adequate levels.
- MORE HEALTH
- Dietary needs change with age; Here are some rules to simplify eating healthy
- Drinking beer, hard liquor is worse for waistline and cardiovascular health than wine
- Jefferson Health to develop proton therapy center in Northeast Philadelphia
While the protection was weaker among Black women, those with sufficient levels had an 11% lower rate of breast cancer, the data also showed.
Researchers from the study analyzed blood samples from 290 Black and 125 Hispanic women who later developed breast cancer. They then compared these samples to those of 1,010 Black and 437 Hispanic women who didn't develop the disease.
"Because women who identify as members of these groups have lower vitamin D levels, on average, than non-Hispanic white women, they could potentially receive enhanced health benefits from interventions promoting vitamin D intake," Katie O’Brien, staff scientist at the National Institute of Environmental Health Sciences, explained. "However, questions remain about whether these associations are truly causal and, if so, what levels of vitamin D are most beneficial."
The study's findings are significant because of the heightened risk for breast cancer mortality among Hispanic and Black women. Breast cancer is the leading cause of cancer death among Hispanic women. Additionally, Black women have a 31% breast cancer mortality rate, which is the highest of any racial or ethnic group in the United States.
Black women under age 45 are more likely to be diagnosed with breast cancer than their white counterparts. They also have a higher risk of developing a more aggressive form of the disease.
While the connection between vitamin D and breast cancer isn't completely clear, previous studies have suggested a link between a deficiency in the vitamin and tumor progression and metastases through the expression of ID1 – a gene with the potential to cause cancer.
Factors such as obesity, dark skin pigmentation, geographical location and prevalence of poor kidney function may contribute to the vitamin deficiency among Black and Hispanic women.
Lactose intolerance and variations in the vitamin D receptor gene are also thought to be possible explanations for insufficient vitamin D levels in Black women. The vitamin D receptor allows the body to respond to vitamin D acquired either through food or sunlight exposure.
O'Brien and colleagues emphasized that their study was not designed to determine a cause-and-effect link between vitamin D and breast cancer.
Most experts agree that there is currently not enough evidence to support recommending vitamin D supplementation to reduce breast cancer risk or change breast density.